ATE289512T1 - Arzneimittel zur behandlung der mucositis, stomatitis und des behcetschen syndroms - Google Patents

Arzneimittel zur behandlung der mucositis, stomatitis und des behcetschen syndroms

Info

Publication number
ATE289512T1
ATE289512T1 AT01980213T AT01980213T ATE289512T1 AT E289512 T1 ATE289512 T1 AT E289512T1 AT 01980213 T AT01980213 T AT 01980213T AT 01980213 T AT01980213 T AT 01980213T AT E289512 T1 ATE289512 T1 AT E289512T1
Authority
AT
Austria
Prior art keywords
mucositis
behcet
stomatitis
syndrome
treatment
Prior art date
Application number
AT01980213T
Other languages
German (de)
English (en)
Inventor
Marco Mastrodonato
Original Assignee
Sinclair Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinclair Pharmaceuticals Ltd filed Critical Sinclair Pharmaceuticals Ltd
Application granted granted Critical
Publication of ATE289512T1 publication Critical patent/ATE289512T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Physiology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
AT01980213T 2000-07-28 2001-07-18 Arzneimittel zur behandlung der mucositis, stomatitis und des behcetschen syndroms ATE289512T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000MI001732A IT1318649B1 (it) 2000-07-28 2000-07-28 Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
PCT/EP2001/008303 WO2002009637A2 (en) 2000-07-28 2001-07-18 Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome

Publications (1)

Publication Number Publication Date
ATE289512T1 true ATE289512T1 (de) 2005-03-15

Family

ID=11445589

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01980213T ATE289512T1 (de) 2000-07-28 2001-07-18 Arzneimittel zur behandlung der mucositis, stomatitis und des behcetschen syndroms

Country Status (25)

Country Link
US (1) US20020173485A1 (enExample)
EP (1) EP1313489B1 (enExample)
JP (1) JP2004505028A (enExample)
KR (1) KR100761051B1 (enExample)
CN (1) CN1198625C (enExample)
AR (1) AR030068A1 (enExample)
AT (1) ATE289512T1 (enExample)
AU (2) AU1211302A (enExample)
BR (1) BRPI0112962B8 (enExample)
CA (1) CA2424346C (enExample)
CZ (1) CZ301461B6 (enExample)
DE (1) DE60109044T2 (enExample)
ES (1) ES2236324T3 (enExample)
HR (1) HRP20030046B1 (enExample)
IT (1) IT1318649B1 (enExample)
MX (1) MXPA03000712A (enExample)
MY (1) MY130477A (enExample)
NO (1) NO329574B1 (enExample)
NZ (1) NZ523832A (enExample)
PL (1) PL204397B1 (enExample)
PT (1) PT1313489E (enExample)
RU (1) RU2272636C2 (enExample)
UA (1) UA79075C2 (enExample)
WO (1) WO2002009637A2 (enExample)
ZA (1) ZA200300712B (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1997478T3 (da) 2001-02-15 2013-12-09 Access Pharma Inc Flydende formuleringer til forebyggelse og behandling af slimhindesygdomme og -lidelser
US7544348B2 (en) 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US6585997B2 (en) 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
JP2005530768A (ja) 2002-05-09 2005-10-13 メディジーンズ 血漿または血清を含有した創傷治療用医薬組成物
US20060234977A1 (en) * 2003-01-23 2006-10-19 Gina Wenham Antiviral compostion comprising a sulphated glucose polymer and a bacteriostatic agent
GB0312485D0 (en) * 2003-05-30 2003-07-09 Dodson & Horrell Horse food composition
ITMI20031291A1 (it) 2003-06-25 2004-12-26 Ricerfarma Srl Uso di acido ialuronico per la preparazione di composizioni per il trattamento di afte del cavo orale.
AU2003265624B2 (en) * 2003-08-21 2011-03-31 Abeona Therapeutics Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US7323184B2 (en) 2005-08-22 2008-01-29 Healagenics, Inc. Compositions and methods for the treatment of wounds and the reduction of scar formation
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
EP2059206B8 (en) * 2006-08-28 2012-07-11 Rexaderm, Inc. Dry wound dressing and drug delivery system
KR100758636B1 (ko) * 2006-12-19 2007-09-13 고려대학교 산학협력단 생체 점막 점착성 고분자 접합체 및 이의 제조방법
DK3354276T3 (da) 2007-11-13 2020-03-30 Meritage Pharma Inc Sammensætninger til behandlingen af gastrointestinal inflammation
US20090143343A1 (en) 2007-11-13 2009-06-04 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20090264392A1 (en) * 2008-04-21 2009-10-22 Meritage Pharma, Inc. Treating eosinophilic esophagitis
GB0813589D0 (en) * 2008-07-24 2008-09-03 Sinclair Pharmaceuticals Ltd Composition
WO2010136872A2 (en) * 2009-05-25 2010-12-02 Pharcoterm S.R.L. Use of a glycosaminoglycan fixed combination and chewable composition comprising said fixed combination
WO2011130414A1 (en) 2010-04-14 2011-10-20 Altria Client Services Inc. Preformed smokeless tobacco product
RU2552936C2 (ru) 2010-11-12 2015-06-10 Колгейт-Палмолив Компани Продукт для ухода за полостью рта и способы его применения и получения
ES2388281B1 (es) 2010-12-27 2013-10-01 Laboratorios Viñas S.A. Composición farmacéutica que comprende ácido hialurónico y un compuesto de zinc y pastilla con palito y procedimiento para preparación correspondientes
ITMI20110954A1 (it) * 2011-05-26 2012-11-27 Professional Dietetics Srl Combinazioni per il trattamento delle mucositi vaginali o rettali
US10799548B2 (en) * 2013-03-15 2020-10-13 Altria Client Services Llc Modifying taste and sensory irritation of smokeless tobacco and non-tobacco products
WO2015056196A1 (en) * 2013-10-16 2015-04-23 Orahealth Corporation Treating mucosal lesions with hyaluronan delivered from an adhering troche
CN105342987A (zh) * 2015-12-04 2016-02-24 亚飞（上海）生物医药科技有限公司 一种凝胶及其制备方法和应用
ITUA20161822A1 (it) * 2016-03-18 2017-09-18 Indena Spa Composizioni utili nella prevenzione e/o nel trattamento di patologie del cavo orale, delle prime vie aeree e dell’esofago
KR102426461B1 (ko) * 2016-07-27 2022-07-29 가부시키가이샤 리타파마 구강 점막 부착재 및 그의 제조 방법
IT201600079773A1 (it) * 2016-07-29 2018-01-29 Matteo Bevilacqua Composizioni contenenti oligosaccaridi di acido ialuronico (HA4), condroitin solfato (CS2-4) ed eparan solfato (HS2-4), triterpeni pentaciclici e derivati per uso medico curativo e metodo per la preparazione di tali composizioni.
CN106176863A (zh) * 2016-08-04 2016-12-07 陈广圣 一种医用抗菌剂
CN107802641A (zh) * 2016-09-09 2018-03-16 李明典 口腔软组织(牙龈、粘膜)抗发炎酸痛剂
EP3459368B1 (en) * 2017-09-20 2025-08-20 Geophyt S.r.L. Food integrator for antineoplastic therapies
CN109331023A (zh) * 2018-11-12 2019-02-15 沈阳药科大学 甘草次酸的医药用途
KR102475125B1 (ko) 2019-08-07 2022-12-07 고려대학교 산학협력단 일산화질소 복합체를 포함하는 구강 점막염 치료용 조성물 및 구강 점막염 치료제
ES2976023T3 (es) * 2019-10-25 2024-07-19 Mucocort Ab Tratamiento de afección inflamatoria en la membrana mucosa o la piel con bajas cantidades de propilenglicol
IT202100011879A1 (it) * 2021-05-10 2022-11-10 Aurora Biofarma S R L Composizione orale per il trattamento delle esofagiti
CN116370333A (zh) * 2021-12-24 2023-07-04 太阳星光齿磨公司 含β-甘草次酸的组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2092442B (en) * 1981-02-06 1984-02-08 Biorex Laboratories Ltd Pharmaceutical composition for treating diseases of the oral cavity containing glycyrrhetinic acid or a derivative thereof
ZA82361B (en) * 1981-02-06 1982-12-29 Biorex Laboratories Ltd Pharmaceutical composition for treating diseases of the oral cavity
JPS6117510A (ja) * 1984-07-03 1986-01-25 Toyobo Co Ltd 口腔粘膜適用徐放性ニフエジピン製剤
JPS6440423A (en) * 1987-08-05 1989-02-10 Kyukyu Yakuhin Kogyo Kk Patch for mucosa in oral cavity
US4965253A (en) * 1987-10-14 1990-10-23 University Of Florida Viscoelastic material for ophthalmic surgery
IT1240316B (it) * 1990-02-21 1993-12-07 Ricerca Di Schiena Del Dr. Michele G. Di Schiema & C. Composizioni a base di acido ialuronico ad alto peso molecolare somministrabili per via topica per il trattamento di infiammazioni del cavo orale ,per la cosmetica e l'igiene del cavo orale
FR2720937B1 (fr) * 1994-06-08 1997-03-28 Oreal Composition cosmétique ou dermatologique sous forme de dispersion, aqueuse et stable, de particules de gel cubique à base de phytantriol et contenant un agent tensioactif à chaîne grasse en tant qu'agent dispersant et stabilisant.
JPH09169652A (ja) * 1995-12-18 1997-06-30 Lion Corp 水性液状組成物
JPH10182390A (ja) * 1996-12-25 1998-07-07 Lion Corp 口腔用組成物
JP2000178185A (ja) * 1998-12-18 2000-06-27 Lion Corp 口腔粘膜付着型徐放性錠剤

Also Published As

Publication number Publication date
CA2424346A1 (en) 2002-02-07
JP2004505028A (ja) 2004-02-19
CZ301461B6 (cs) 2010-03-10
CN1474700A (zh) 2004-02-11
KR20030069979A (ko) 2003-08-27
ITMI20001732A0 (it) 2000-07-28
IT1318649B1 (it) 2003-08-27
AU2002212113B2 (en) 2006-01-12
ZA200300712B (en) 2004-02-09
WO2002009637A3 (en) 2002-12-05
AU1211302A (en) 2002-02-13
ITMI20001732A1 (it) 2002-01-28
DE60109044D1 (de) 2005-03-31
MXPA03000712A (es) 2004-11-01
NO20030411L (no) 2003-01-27
KR100761051B1 (ko) 2007-10-04
BRPI0112962B8 (pt) 2021-05-25
NO329574B1 (no) 2010-11-15
UA79075C2 (uk) 2007-05-25
NO20030411D0 (no) 2003-01-27
BR0112962A (pt) 2003-06-24
HRP20030046A2 (en) 2004-04-30
HRP20030046B1 (hr) 2011-08-31
PL362921A1 (en) 2004-11-02
PT1313489E (pt) 2005-05-31
DE60109044T2 (de) 2005-07-21
CA2424346C (en) 2010-03-09
EP1313489B1 (en) 2005-02-23
AR030068A1 (es) 2003-08-13
CN1198625C (zh) 2005-04-27
EP1313489A2 (en) 2003-05-28
WO2002009637A2 (en) 2002-02-07
ES2236324T3 (es) 2005-07-16
RU2272636C2 (ru) 2006-03-27
NZ523832A (en) 2003-09-26
BR0112962B1 (pt) 2013-12-31
HK1059215A1 (en) 2004-06-25
PL204397B1 (pl) 2010-01-29
MY130477A (en) 2007-06-29
US20020173485A1 (en) 2002-11-21

Similar Documents

Publication Publication Date Title
DE60109044D1 (de) Arzneimittel zur behandlung der mucositis, stomatitis und des behcetschen syndroms
DE60235719D1 (de) Frauenhygieneartikel zur verabreichung von arzneimittel
DE60108080D1 (de) Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen
NO20041216L (no) Imidazol-4-karboksamidderivater, fremstilling og anvendelse derav for behandling av overvekt
ATE291438T1 (de) Pharmazeutische zusammensetzung zur behandlung von akutem schmerz, chronischem schmerz und/oder neuropathischem schmerz und migräne
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
NO963568D0 (no) Farmasöytisk preparat for behandling av blodkoagulasjonssykdommer, fremgangsmåter for fremstilling av dette og dets anvendelse
DE69940131D1 (de) Mittel zur Behandlung von Erkrankungen der Speiseröhre
ATE295174T1 (de) Arzneimittel zur behandlung von bluthochdruck
EE200200717A (et) Ravimpreparaat ängistusneuroosi või depressiooni raviks ja piperasiiniderivaadid
DE60132851D1 (de) Arzneimittel zur Vorbeugung, Erleichterung oder Behandlung von Hypertension
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
EE200200271A (et) Ravimkombinatsioonid ning nende kasutamine
DE60027209D1 (de) Arzneimittel enthaltend hydroxyapatite zur behandlung von knochengewebserkrankungen
ATE431142T1 (de) Arzneimittel zur behandlung und vermeidung neurogener schmerzen
DE60139783D1 (de) Gen und pflanzenextrakte, wirksam zur behandlung und prävention von chlamydieninfektionen
DE59914712D1 (de) Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden
HUP0301506A3 (en) Pharmaceutical compositions for the treatment of painful, inflammatory and ulcerative conditions of moist epithelial surfaces such as mucositis, stomatitis and behcet's syndrome
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
DE69937692D1 (de) Arzneimittel zur behandlung der hemicrania
ATE210976T1 (de) Arzneimittel bestehend aus diclofenac
NO20032597L (no) Anvendelse av SARP-1 for behandlingen og/eller forebyggingen av skleroderma
DE60125212D1 (de) Verwendung von Aivlosin zur Behandlung und Prevention der Lawsonia-Infektionen in Schweinen.
DE60107900D1 (de) Pharmazeutische Zusammensetzung und Nahrungsmittel zur Behandlung von Gehirnödem

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1313489

Country of ref document: EP